Indications for use:
In hyperammonemia as a result of acute and chronic liver diseases such as:

  • liver cirrhosis
  • fatty liver
  • hepatitis
  • especially for the treatment of incipient disturbances of consciousness (pre-coma) or neurological complications (hepatic encephalopathy). Since ornithine aspartate exerts its action in the
    metabolic cycles of the liver, elevated blood ammonia levels are rapidly lowered. The capacity of detoxification, particularly of the urea cycle, is enhanced.

Full Product Information